{"id":40594,"date":"2004-08-01T12:09:00","date_gmt":"2004-08-01T10:09:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin"},"modified":"2004-08-01T12:09:00","modified_gmt":"2004-08-01T10:09:00","slug":"loratadin-oder-desloratadin-cetirizin-oder-levocetirizin","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/","title":{"rendered":">Loratadin oder Desloratadin? Cetirizin oder Levocetirizin?"},"content":{"rendered":"<p>Dr. A.W. aus W\u00fcrzburg schreibt: >> \u2026 die Deutsche Gesellschaft f\u00fcr Allergologie kl\u00e4rt \u00fcber den Gebrauch von rezeptfreien und rezeptpflichtigen antiallergischen Medikamenten auf. Die Kernfrage, ob der rezeptfreie Wirkstoff Loratadin tats\u00e4chlich Nachteile gegen\u00fcber dem rezeptpflichtigen Wirkstoff Desloratadin hat, wird nicht er\u00f6rtert. Genau dieselbe \u00dcberlegung gilt f\u00fcr den Vergleich Cetirizin und Levocetirizin. Welche Erkenntnisse gibt es [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. A.W. aus W\u00fcrzburg schreibt: >> \u2026 die Deutsche Gesellschaft f\u00fcr Allergologie kl\u00e4rt \u00fcber den Gebrauch von rezeptfreien und rezeptpflichtigen antiallergischen Medikamenten auf. Die Kernfrage, ob der rezeptfreie Wirkstoff Loratadin tats\u00e4chlich Nachteile gegen\u00fcber dem rezeptpflichtigen Wirkstoff Desloratadin hat, wird nicht er\u00f6rtert. Genau dieselbe \u00dcberlegung gilt f\u00fcr den Vergleich Cetirizin und Levocetirizin. Welche Erkenntnisse gibt es [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[4437,4669,5610,5663],"class_list":["post-40594","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-cetirizin","tag-desloratadin","tag-levocetirizin","tag-loratadin"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>&gt;Loratadin oder Desloratadin? Cetirizin oder Levocetirizin? - Der Arzneimittelbrief<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"&gt;Loratadin oder Desloratadin? Cetirizin oder Levocetirizin? - Der Arzneimittelbrief\" \/>\n<meta property=\"og:description\" content=\"Dr. A.W. aus W\u00fcrzburg schreibt: &gt;&gt; \u2026 die Deutsche Gesellschaft f\u00fcr Allergologie kl\u00e4rt \u00fcber den Gebrauch von rezeptfreien und rezeptpflichtigen antiallergischen Medikamenten auf. Die Kernfrage, ob der rezeptfreie Wirkstoff Loratadin tats\u00e4chlich Nachteile gegen\u00fcber dem rezeptpflichtigen Wirkstoff Desloratadin hat, wird nicht er\u00f6rtert. Genau dieselbe \u00dcberlegung gilt f\u00fcr den Vergleich Cetirizin und Levocetirizin. Welche Erkenntnisse gibt es [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2004-08-01T10:09:00+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2012\/06\/logo_amb_neu.jpg\" \/>\n<meta name=\"author\" content=\"Dennis Hoppe\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dennis Hoppe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\\\/\"},\"author\":{\"name\":\"Dennis Hoppe\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"headline\":\">Loratadin oder Desloratadin? Cetirizin oder Levocetirizin?\",\"datePublished\":\"2004-08-01T10:09:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\\\/\"},\"wordCount\":191,\"keywords\":[\"Cetirizin\",\"Desloratadin\",\"Levocetirizin\",\"Loratadin\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\\\/\",\"name\":\">Loratadin oder Desloratadin? Cetirizin oder Levocetirizin? - Der Arzneimittelbrief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"datePublished\":\"2004-08-01T10:09:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\">Loratadin oder Desloratadin? Cetirizin oder Levocetirizin?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\",\"name\":\"Dennis Hoppe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"caption\":\"Dennis Hoppe\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":">Loratadin oder Desloratadin? Cetirizin oder Levocetirizin? - Der Arzneimittelbrief","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/","og_locale":"de_DE","og_type":"article","og_title":">Loratadin oder Desloratadin? Cetirizin oder Levocetirizin? - Der Arzneimittelbrief","og_description":"Dr. A.W. aus W\u00fcrzburg schreibt: >> \u2026 die Deutsche Gesellschaft f\u00fcr Allergologie kl\u00e4rt \u00fcber den Gebrauch von rezeptfreien und rezeptpflichtigen antiallergischen Medikamenten auf. Die Kernfrage, ob der rezeptfreie Wirkstoff Loratadin tats\u00e4chlich Nachteile gegen\u00fcber dem rezeptpflichtigen Wirkstoff Desloratadin hat, wird nicht er\u00f6rtert. Genau dieselbe \u00dcberlegung gilt f\u00fcr den Vergleich Cetirizin und Levocetirizin. Welche Erkenntnisse gibt es [&hellip;]","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2004-08-01T10:09:00+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2012\/06\/logo_amb_neu.jpg","type":"","width":"","height":""}],"author":"Dennis Hoppe","twitter_misc":{"Verfasst von":"Dennis Hoppe","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/"},"author":{"name":"Dennis Hoppe","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"headline":">Loratadin oder Desloratadin? Cetirizin oder Levocetirizin?","datePublished":"2004-08-01T10:09:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/"},"wordCount":191,"keywords":["Cetirizin","Desloratadin","Levocetirizin","Loratadin"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/","name":">Loratadin oder Desloratadin? Cetirizin oder Levocetirizin? - Der Arzneimittelbrief","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"datePublished":"2004-08-01T10:09:00+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/loratadin-oder-desloratadin-cetirizin-oder-levocetirizin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":">Loratadin oder Desloratadin? Cetirizin oder Levocetirizin?"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16","name":"Dennis Hoppe","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","caption":"Dennis Hoppe"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/40594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=40594"}],"version-history":[{"count":0,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/40594\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=40594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=40594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=40594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}